LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 114 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.30 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 434 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 434 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 434 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 434 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 434 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 434 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 434 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 434 | -25.6% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 583 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 583 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 583 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 583 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 583 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | +33.3% | 583 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -25.0% | 583 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 583 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -14.3% | 583 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +40.0% | 583 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 583 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $62,009,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $825,383,000 | 17.04% |
| NEA Management Company, LLC | 2,382,286 | $34,186,000 | 1.77% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $512,000 | 1.49% |
| BRIDGER MANAGEMENT, LLC | 1,029,926 | $14,779,000 | 0.95% |
| FALCON POINT CAPITAL, LLC | 287,809 | $4,130,000 | 0.71% |
| HANCOCK WHITNEY CORP | 664,025 | $9,529,000 | 0.40% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 494,380 | $7,094,000 | 0.39% |
| ELLINGTON MANAGEMENT GROUP LLC | 11,700 | $168,000 | 0.23% |
| Convergence Investment Partners, LLC | 114,157 | $1,638,000 | 0.22% |